Focus Partners Wealth
IRWD icon

Focus Partners Wealth’s Ironwood Pharmaceuticals IRWD Stock Holding History

Focus Partners Wealth’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Sell
44,920
-12,265
-21% -$47.3K ﹤0.01% 2520
2026
Q1 		$201K Buy
57,185
+13,220
+30% +$54.2K ﹤0.01% 2424
2025
Q4 		$148K Sell
43,965
-687
-2% -$1.78K ﹤0.01% 2497
2025
Q3 		$58.5K Buy
44,652
+10,105
+29% +$10.5K ﹤0.01% 2156
2025
Q2 		$24.8K Buy
+34,547
New +$27.1K ﹤0.01% 2000

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Focus Partners Wealth's IRWD Position: Q2 2026 in Review

Focus Partners Wealth reduced its Ironwood Pharmaceuticals (IRWD) stake by 21% in Q2 2026, selling an estimated $47.3K and leaving 44,920 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2520.

Focus Partners Wealth first reported a position in IRWD in Q2 2025 and has held it in 5 quarters since. The position peaked at $201K in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Focus Partners Wealth held 44,920 shares of Ironwood Pharmaceuticals worth $189K as of Q2 2026.
  • Focus Partners Wealth sold 12,265 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $47.3K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2520 holding.
  • Focus Partners Wealth first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Focus Partners Wealth's Ironwood Pharmaceuticals position peaked at $201K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.